Director/PDMR Shareholding

RNS Number : 9187W

GlaxoSmithKline PLC

29 April 2016

 

GlaxoSmithKline plc

 Notification of Transactions of Directors, Persons Discharging

Managerial Responsibilities or Connected Persons

The Administrators of the GlaxoSmithKline 2009 Performance Share Plan (the 'Plan') notified GlaxoSmithKline plc ('GSK') on 28 April 2016 that the under-mentioned Directors, Persons Discharging Managerial Responsibilities ('PDMR') and Connected Persons acquired notional Ordinary Shares at a price of 1502.00 pence per Ordinary Share and American Depositary Shares ('ADSs') at a price of $42.64 per ADS, following the notional re-investment of the dividend paid to shareholders on 14 April 2016.

Director/PDMR	Ordinary Shares	ADSs
Sir Andrew Witty	41,688.082
Dr M M Slaoui		12,095.870
Mr S Dingemans	17,503.320
Mr R G Connor	8,568.501
Mr N Hirons	2,666.231	215.628
Mr S A Hussain	17,903.405
Mr D S Redfern	6,379.260
Ms C Thomas	8,495.290
Mr P C Thomson	4,638.016
Mr D E Troy		7,534.332
Dr P J T Vallance	18,629.480
Ms E Walmsley	14,203.165
Mrs V A Whyte	1,072.219

Connected Person	Ordinary Shares	ADSs
Dr K Slaoui (Connected Person to Dr M M Slaoui)		184.627

The notional dividends accrued will be paid out in proportion to the percentage of participants' Plan holdings that vest following the end of the relevant measurement period.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a) and (c).

V A Whyte

Company Secretary

29 April 2016

 

END

 

 

DSHQKLFLQZFZBBL